Department of Obstetrics & Gynecology

Medicine & Life Sciences

1. Ovarian Neoplasms 100%
2. Pelvic Organ Prolapse 74%
3. Carcinoma 67%
4. Neoplasms 65%
5. Endometrial Neoplasms 39%
6. Therapeutics 38%
7. Prolapse 38%
8. Cervix Uteri 36%
9. Pregnancy 35%
10. Vulva 33%
11. Hysterectomy 32%
12. Vagina 32%
13. Skin 30%
14. Cholesterol 29%
15. Docetaxel 28%
16. Endometriosis 25%
17. Zebrafish 25%
18. Growth 22%
19. Pelvic Floor 21%
20. Ovarian Epithelial Carcinoma 21%
21. Gynecologic Surgical Procedures 20%
22. Relaxin 20%
23. Atherosclerosis 20%
24. Granulosa Cell Tumor 20%
25. Lipids 19%
26. Stress Urinary Incontinence 19%
27. Endothelial Cells 19%
28. Dyspareunia 19%
29. Recurrence 18%
30. Topotecan 18%
31. Fecal Incontinence 18%
32. Systematic Reviews 17%
33. Drug Therapy 17%
34. Carrier Proteins 17%
35. Uterine Cervical Neoplasms 17%
36. Small Interfering RNA 17%
37. Cell-Free Nucleic Acids 17%
38. Homocysteine 16%
39. Squamous Cell Carcinoma 16%
40. Thymidine Kinase 15%
41. Focal Adhesion Protein-Tyrosine Kinases 15%
42. Polypropylenes 15%
43. Liposomes 14%
44. Breast Neoplasms 14%
45. In Vitro Techniques 14%
46. Vascular Endothelial Growth Factor A 14%
47. Pharmaceutical Preparations 14%
48. Genes 14%
49. Microvessels 14%
50. Macrophages 14%
51. Blood Vessels 13%
52. Uterine Prolapse 13%
53. Lipoproteins 13%
54. cholesterol-binding protein 12%
55. Vaginal Hysterectomy 12%
56. Thioctic Acid 12%
57. Pelvis 12%
58. Neoplasm Metastasis 12%
59. Papanicolaou Test 12%
60. Transplants 12%
61. Gynecology 12%
62. Survival 12%
63. DNA 12%
64. Diet 12%
65. Rabbits 12%
66. Larva 12%
67. Genetic Therapy 11%
68. Ovariectomy 11%
69. Fertilization in Vitro 11%
70. Ovary 11%
71. Surgeons 11%
72. Urinary Incontinence 11%
73. Adenocarcinoma 11%
74. Robotics 10%
75. Medicine 10%
76. Fertility 10%
77. Matrix Metalloproteinases 10%
78. Fallopian Tube Neoplasms 10%
79. Uterus 10%
80. Progesterone Receptors 10%
81. Pandemics 10%
82. Infertility 10%
83. Endometrium 10%
84. Tumor Burden 9%
85. Hemorrhage 9%
86. Inflammation 9%
87. Biopsy 9%
88. Diethylstilbestrol 9%
89. Intrauterine Blood Transfusion 9%
90. Paclitaxel 9%
91. Incidence 9%
92. Leiomyoma 9%
93. Squamous Cell Neoplasms 9%
94. Anti-Bacterial Agents 9%
95. Abscess 9%
96. Suspensions 9%
97. Confidence Intervals 9%
98. Cardiovascular Diseases 9%